Nearly 40 years after his death, Elvis Presley is still the King. See how much you know about this icon of movies, music, pop culture and unusual appetites. (Fried peanut butter and banana sandwiches anyone?)
Johnson & Johnson MedTech innovates at the intersection of biology and technology. With a focus on treating with pinpoint precision in the hardest-to-reach parts of the body, restoring anatomy and reimagining healing, our portfolio of smarter, less invasive, more personalized treatments is addressing the most complex health challenges. Healthcare areas include: Cardiovascular, Orthopaedics ...
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated and cured, treatments are smarter and less invasive and solutions are personal.
Johnson & Johnson reports Q1 2026 results, raises 2026 outlook 2026 First-Quarter reported sales growth of 9.9% to $24.1 Billion with operational growth of 6.4%* and adjusted operational growth of 5.3%* 2026 First-Quarter earnings per share (EPS) of $2.14 and adjusted EPS of $2.70 Company increases 2026 guidance with estimated reported sales of $100.8 Billion or 7.0% at the ...
The brother of Johnson & Johnson cofounders Robert Wood Johnson and James Wood Johnson, Edward Mead Johnson led the company’s sales and marketing division in the 19 th century. In 1898, Edward Mead left Johnson & Johnson, taking with him the company’s digestive products line, a business that would eventually become a leading global company in the field of infant and child nutrition.
NEW BRUNSWICK, N.J.-- (BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full-year 2025. “2025 was a catapult year for Johnson & Johnson, fueled by the strongest portfolio and pipeline in our history,” said Joaquin Duato, Chairman and Chief Executive Officer, Johnson & Johnson. “Last year kicked off a new era of accelerated growth, driven by ...